159 results
8-K
CYTH
Cyclo Therapeutics Inc - Ordinary Shares
27 Dec 23
Completion of Acquisition or Disposition of Assets
8:25pm
affirmatively determined that Mr. Cross qualifies as an “independent director” under the applicable rules and regulations of The Nasdaq Stock Market
425
qr6o40
18 Dec 23
Business combination disclosure
6:02am
8-K
yvo89o66n4g
18 Dec 23
Other Events
6:01am
424B3
fceh1
21 Nov 23
Prospectus supplement
9:15am
S-4/A
kx0g1
20 Nov 23
Registration of securities issued in business combination transactions (amended)
8:50am
S-4/A
EX-23.2
67qyx
20 Nov 23
Registration of securities issued in business combination transactions (amended)
8:50am
S-4/A
EX-23.3
7jvtew9k
20 Nov 23
Registration of securities issued in business combination transactions (amended)
8:50am
S-4
EX-23.2
iw0mnhaey 17yisd23ga
7 Nov 23
Registration of securities issued in business combination transactions
4:45pm
S-4
EX-23.3
fgyqn83uhfcfavg135f
7 Nov 23
Registration of securities issued in business combination transactions
4:45pm
S-4
vfm6lwj
7 Nov 23
Registration of securities issued in business combination transactions
4:45pm
8-K
EX-4.1
rdrtfz5lfrg
20 Oct 23
Unregistered Sales of Equity Securities
2:19pm
425
EX-2.1
lyrtc
21 Sep 23
Business combination disclosure
4:28pm
8-K
EX-2.1
fjv3uh9fdxdaxc
21 Sep 23
Cyclo Therapeutics, Inc. and Applied Molecular Transport Inc. Enter into a Definitive Merger Agreement
4:28pm
8-K
m0v6zk
21 Aug 23
Departure of Directors or Certain Officers
8:00am
8-K
EX-4.1
tw8f1nk1iek
3 Aug 23
Unregistered Sales of Equity Securities
4:03pm